Dandelion Root
Dandelion Root, licence 00827789: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Nature's Way of Canada Ltd.
- NPN or DIN-HM
- 00827789
- Status
- Active licence
- Licence date
- 4 April 2007
- Revision date
- 22 October 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine végétale, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Traditionally used to stimulate appetite and to increase bile flow.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking diabetes or psychoactive medications.
- Contre-indications
Do not use if you are pregnant, breastfeeding, allergic to Asteraceae (daisy family) plants, have Gilbert's syndrome or Crigler-Najjar syndrome, gall baldder inflammation, bile duct obstruction or cancer, intestinal blockage, pancreatic cancer, hemolytic anemia, liver cancer or liver disease.
Source
Official Health Canada record, licence 00827789
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.